AR056125A1 - Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas - Google Patents

Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas

Info

Publication number
AR056125A1
AR056125A1 ARP060104446A ARP060104446A AR056125A1 AR 056125 A1 AR056125 A1 AR 056125A1 AR P060104446 A ARP060104446 A AR P060104446A AR P060104446 A ARP060104446 A AR P060104446A AR 056125 A1 AR056125 A1 AR 056125A1
Authority
AR
Argentina
Prior art keywords
diagnosis
thromboembolies
cardiopatias
ischemical
procedure
Prior art date
Application number
ARP060104446A
Other languages
English (en)
Spanish (es)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR056125A1 publication Critical patent/AR056125A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ARP060104446A 2005-10-12 2006-10-10 Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas AR056125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
AR056125A1 true AR056125A1 (es) 2007-09-19

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104446A AR056125A1 (es) 2005-10-12 2006-10-10 Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas

Country Status (14)

Country Link
US (1) US20090197774A1 (https=)
EP (1) EP1937839B1 (https=)
JP (1) JP2009511026A (https=)
KR (1) KR20080052662A (https=)
CN (1) CN101287846A (https=)
AR (1) AR056125A1 (https=)
AT (1) ATE525481T1 (https=)
AU (1) AU2006301578B9 (https=)
BR (1) BRPI0617341A2 (https=)
CA (1) CA2625698A1 (https=)
DE (1) DE102005048899A1 (https=)
IL (1) IL190585A (https=)
TW (1) TW200734638A (https=)
WO (1) WO2007042165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
CA2685382C (en) 2007-05-01 2023-02-21 The Regents Of The University Of California Methods for diagnosing ischemia
CA2804763C (en) 2010-07-14 2023-01-03 The Regents Of The University Of California Biomarkers for diagnosis of transient ischemic attacks
WO2012009567A2 (en) 2010-07-15 2012-01-19 The Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
WO2012121978A2 (en) 2011-03-04 2012-09-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
EP3290924B1 (en) * 2011-12-01 2021-10-13 Roche Diagnostics GmbH Nt-proanp and nt-probnp for the diagnosis of stroke
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
KR101939778B1 (ko) 2012-07-27 2019-01-18 삼성전자주식회사 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치
CN119846215B (zh) * 2025-01-22 2025-07-11 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306913B2 (en) * 2002-12-20 2007-12-11 Applera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
WO2004058052A2 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof

Also Published As

Publication number Publication date
CN101287846A (zh) 2008-10-15
KR20080052662A (ko) 2008-06-11
JP2009511026A (ja) 2009-03-19
EP1937839B1 (de) 2011-09-21
WO2007042165A1 (de) 2007-04-19
ATE525481T1 (de) 2011-10-15
IL190585A0 (en) 2008-11-03
CA2625698A1 (en) 2007-04-19
AU2006301578A1 (en) 2007-04-19
DE102005048899A1 (de) 2007-04-19
EP1937839A1 (de) 2008-07-02
AU2006301578B9 (en) 2011-12-22
AU2006301578B2 (en) 2011-12-01
US20090197774A1 (en) 2009-08-06
IL190585A (en) 2011-12-29
BRPI0617341A2 (pt) 2011-07-26
TW200734638A (en) 2007-09-16

Similar Documents

Publication Publication Date Title
WO2008055078A3 (en) Identification of emotional states using physiological responses
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
ATE481032T1 (de) Vorrichtung, system und verfahren zur in-vivo- probenentnahme
DE602005026789D1 (de) Le
EP2498095A3 (en) Use of IGFBP-7 in the assessment of heart failure
CY1109480T1 (el) ΠΡΩΤΕΪΝΕΣ ΣΥΝΔΕΣΗΣ Gag
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
MXPA05006382A (es) Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
WO2008016385A3 (en) Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
TW200637875A (en) Cytotoxicity mediation of cells evidencing surface expression of CD63
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
EP1862433A4 (en) PERSONALIZED SYNTHETIC DIAMOND WITH DIFFERENT COLORS, OBTAINED FROM KERATIN (LIVING OR DEAD) HUMANS OR ANIMALS AND MANUFACTURING PROCESS THEREFOR
WO2006088962A3 (en) Replikin peptides and uses thereof
WO2007010110A3 (fr) Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
AR056831A1 (es) Metodo para el diagnostico y tratamiento de enfermedades cardiovasculares
ATE531791T1 (de) Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon
WO2005115394A3 (en) Prenyl-electrostatic switch, and methods of use
DE60336596D1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
IL211178A0 (en) Association of protein polymorphisms with coronary heart disease

Legal Events

Date Code Title Description
FB Suspension of granting procedure